R&D Scope for action: How the life sciences industry can make pr... With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.
News Public wants pharma to reveal carbon footprint of drugs A survey has found that there is strong consumer support for pharma manufacturers to disclose the carbon footprint of their medicines, amid rising public scrutiny of the e
Market Access Is net-zero an achievable target for pharma? The pharmaceutical industry has arguably been slow to prioritise the environment and sustainable strategies.
Healthcare Bring point of care testing to the community for a preventat... The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new
Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
News Supporting the era of green pharmaceuticals in the UK According to a report by the Office of Health Economics (OHE), commissioned by the Association of th
News Taiho's late-stage Duchenne candidate fails trial Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face